Uses of Vigadexa

Vigadexa drug belongs to the group of drugs used to treat eyes, ears, nose and throat. So what is Vigadexa and how is it used?

Vigadexa drug has the main ingredients containing 2 active ingredients, Moxifloxacin hydrochloride and Dexamethasone, with the concentration of 5mg and 1mg per 1ml of solution, respectively. The drug is prepared in the form of a sterile eye drop solution, packaged in a box with 1 vial of 5ml capacity.

2.1. Indications Vigadexa drug Vigadexa drug is indicated for treatment in the following cases: Using Vigadexa to prevent inflammation and infection after eye surgery, treatment in eye infections.
2.2. Vigadexa drug is contraindicated Vigadexa drug is contraindicated for use in the following cases:
Patients with hypersensitivity to any ingredient of the drug including active ingredients Moxifloxacin, Dexamethasone or other Quinolones and excipients in Vigadexa drug . Patients with herpes simplex virus keratitis, chickenpox, cowpox or other viral infections of the cornea or conjunctiva. Tuberculosis of the eye, caused by fungi of the eye structures, glaucoma, diseases that cause thinning of the sclera or cornea of ​​the eye.

3.1. How to use Vigadexa Instruct patients to close their eyes or press on the tear duct to limit absorption of Vigadexa to help reduce unwanted systemic effects. If the patient is using 2 or more types of eye drops, they should be used at least 5 minutes apart, if there is eye ointment, it should be used last.
When using, should avoid contact with the dropper of Vigadexa in the eye or any object to avoid contamination of the dropper. Do not touch the dropper tip with your hands, close the cap tightly after use.
3.2. Dosage of Vigadexa The dosage of Vigadexa depends on the patient's medical condition, some recommended doses are as follows:
For patients with eye infections: use 4 times a day, 1 time 1 drop, use for 7 days. Prevention of inflammation and infection after eye surgery: use for the surgical eye 4 times a day, 1 drop 1 time. For patients to use 1 day before surgery and continue for 15 days after surgery (for patients with refractive surgery with LASIK, use the drug about 15 minutes after surgery, and cataracts can be used immediately. Vigadexa after surgery 3.3 Treatment of overdose
When the patient accidentally drops too much Vigadexa, it is recommended to wash it off immediately with warm water.Do not take more medicine until the next indicated time.

When using Vigadexa, patients may experience side effects such as: lacrimation, decreased vision, conjunctivitis, keratitis, dry eye, eye discomfort, submucosal hemorrhage, erection, difficulty suffering, cough, fever, runny nose, sore throat, pharyngitis, rhinitis, otitis media.
Long-term use of Vigadexa containing the active ingredient Dexamethasone can lead to glaucoma, glaucoma with optic nerve damage, decreased visual acuity, and cataracts. Patients are advised to have their intraocular pressure checked regularly and periodically. Especially for people who are prone to diseases such as diabetics and children.
Fungal infection is likely to be associated with prolonged use of Vigadexa. When experiencing any unwanted effects, patients should immediately report to the doctor so that they can be explained and handled in a timely and effective manner.

Concomitant use of topical NSAIDs increases the risk of corneal healing problems.
The concentration of active substance Dexamethasone phosphate in the blood increases when Vigadexa is used with Ritonavir.

Vigadexa is only used as an eye drop solution, not for injection.
At the first sign of tendinitis or an allergic reaction to moxifloxacin, treatment with Vigadexa should be stopped immediately.
During the use of Vigadexa to treat eye infections, do not use contact lenses until the symptoms are gone. Do not use with other eye drops unless directed by your doctor.
Advise patients about possible temporary blurred vision or visual disturbances after taking Vigadexa that may affect the ability to drive or work related to operating machines or requiring concentration .
For subjects such as pregnant women, lactating mothers, and children, the safety and effectiveness of Vigadexa have not been studied and proven. Vigadexa should not be used in these subjects or unless the potential benefits outweigh the possible risks, all indications must be followed by the treating physician.

It is necessary to follow the principles of drug storage, keep the medicine in a dry place, avoid direct sunlight, the optimal temperature is below 30 degrees Celsius, keep out of reach of children.
Vigadexa vials should be discarded 30 days after opening.
Hopefully with the sharing of Vigadexa drug will help users better understand how to use as well as dosage to get the best treatment results.